1. Home
  2. ANNX vs ZUMZ Comparison

ANNX vs ZUMZ Comparison

Compare ANNX & ZUMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANNX
  • ZUMZ
  • Stock Information
  • Founded
  • ANNX 2011
  • ZUMZ 1978
  • Country
  • ANNX United States
  • ZUMZ United States
  • Employees
  • ANNX N/A
  • ZUMZ N/A
  • Industry
  • ANNX Biotechnology: Pharmaceutical Preparations
  • ZUMZ Clothing/Shoe/Accessory Stores
  • Sector
  • ANNX Health Care
  • ZUMZ Consumer Discretionary
  • Exchange
  • ANNX Nasdaq
  • ZUMZ Nasdaq
  • Market Cap
  • ANNX 334.1M
  • ZUMZ 363.1M
  • IPO Year
  • ANNX 2020
  • ZUMZ 2005
  • Fundamental
  • Price
  • ANNX $2.92
  • ZUMZ $23.16
  • Analyst Decision
  • ANNX Strong Buy
  • ZUMZ Hold
  • Analyst Count
  • ANNX 4
  • ZUMZ 1
  • Target Price
  • ANNX $13.00
  • ZUMZ $18.00
  • AVG Volume (30 Days)
  • ANNX 1.9M
  • ZUMZ 190.1K
  • Earning Date
  • ANNX 11-10-2025
  • ZUMZ 12-04-2025
  • Dividend Yield
  • ANNX N/A
  • ZUMZ N/A
  • EPS Growth
  • ANNX N/A
  • ZUMZ N/A
  • EPS
  • ANNX N/A
  • ZUMZ 0.03
  • Revenue
  • ANNX N/A
  • ZUMZ $900,253,000.00
  • Revenue This Year
  • ANNX N/A
  • ZUMZ $5.50
  • Revenue Next Year
  • ANNX N/A
  • ZUMZ $1.36
  • P/E Ratio
  • ANNX N/A
  • ZUMZ $712.65
  • Revenue Growth
  • ANNX N/A
  • ZUMZ 1.64
  • 52 Week Low
  • ANNX $1.29
  • ZUMZ $11.31
  • 52 Week High
  • ANNX $6.93
  • ZUMZ $24.37
  • Technical
  • Relative Strength Index (RSI)
  • ANNX 45.55
  • ZUMZ 66.03
  • Support Level
  • ANNX $2.66
  • ZUMZ $21.27
  • Resistance Level
  • ANNX $3.03
  • ZUMZ $22.49
  • Average True Range (ATR)
  • ANNX 0.24
  • ZUMZ 0.86
  • MACD
  • ANNX -0.04
  • ZUMZ 0.02
  • Stochastic Oscillator
  • ANNX 26.98
  • ZUMZ 87.10

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

About ZUMZ Zumiez Inc.

Zumiez Inc is a United-States-based specialty retailer engaged in the sale of apparel, footwear, accessories, and hard goods. The company provides merchandise with cultural elements coming from fashion, music, art from action sports, streetwear, and other lifestyles. The company operates under the brands Zumiez, Fast Times, and Blue Tomato, and through both physical stores and websites. The majority of the company's stores are located in the U.S., with the rest in Canada, Australia, and Europe. The U.S. market contributes to the majority of the company's revenue.

Share on Social Networks: